Macrophages: Contributors to allograft dysfunction, repair, or innocent bystanders?

Current Opinion in Organ Transplantation

Volumn 17, Issue 1, 2012, Pages 20-25

  Mannon, Roslyn B ^a  

^a University of Alabama at Birmingham   (United States)

Author keywords

antibody; inflammation; kidney transplant; macrophage; rejection

Indexed keywords

ACUTE GRAFT REJECTION; GRAFT DYSFUNCTION; HUMAN; IN VITRO STUDY; INFLAMMATION; KIDNEY DISEASE; MACROPHAGE; NONHUMAN; ORGAN TRANSPLANTATION; PHENOTYPE; REVIEW;

ACUTE DISEASE; ACUTE KIDNEY INJURY; ANIMALS; CHRONIC DISEASE; GRAFT REJECTION; HUMANS; IMMUNITY, INNATE; INFLAMMATION; KIDNEY TRANSPLANTATION; MACROPHAGES; ORGAN TRANSPLANTATION; TRANSPLANTATION, HOMOLOGOUS;

EID: 84856101688     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0b013e32834ee5b6     Document Type: Review

References (44)

1. Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nat Rev Immunol 2008; 8:958-969.
2. Fleming BD, Mosser DM. Regulatory macrophages: setting the threshold for therapy. Eur J Immunol 2011; 41:2498-2502.
3. A recent review to highlight the biochemical and functional properties of a novel macrophage phenotype designated as the regulatory macrophage. 3. Brem-Exner BG, Sattler C, Hutchinson JA, et al. Macrophages driven to a novel state of activation have anti-inflammatory properties in mice. J Immunol 2008; 180:335-349.
4. Bajwa A, Kinsey GR, Okusa MD. Immune mechanisms and novel pharmacological therapies of acute kidney injury. Curr Drug Targets 2009; 10:1196-1204.
5. Li L, Huang L, Sung SS, et al. The chemokine receptors CCR2 and CX3CR1 mediate monocyte/macrophage trafficking in kidney ischemia-reperfusion injury. Kidney Int 2008; 74:1526-1537.
6. Day YJ, Huang L, Ye H, et al. Renal ischemia-reperfusion injury and adenosine 2A receptor-mediated tissue protection: Role of macrophages. Am J Physiol Renal Physiol 2005; 288:F722-F731. (Pubitemid 40381739)
7. Jang HS, Kim J, Park YK, Park KM. Infiltrated macrophages contribute to recovery after ischemic injury but not to ischemic preconditioning in kidneys. Transplantation 2008; 85:447-455. (Pubitemid 351322770)
8. Duffield JS, Park KM, Hsiao LL, et al. Restoration of tubular epithelial cells during repair of the postischemic kidney occurs independently of bone marrow-derived stem cells. J Clin Invest 2005; 115:1743-1755. (Pubitemid 40979713)
9. Lee S, Huen S, Nishio H, et al. Distinct macrophage phenotypes contribute to kidney injury and repair. J Am Soc Nephrol 2011; 22:317-326.
10. Chevalier RL, Forbes MS, Thornhill BA. Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy. Kidney Int 2009; 75:1145-1152.
11. Zarjou A, Yang S, Abraham E, et al. Identification of a microRNA signature in renal fibrosis: Role of miR-21. Am J Physiol Renal Physiol 2011; 301:F793-F801.
12. Magil AB. Monocytes/macrophages in renal allograft rejection. Transplant Rev (Orlando) 2009; 23:199-208.
13. Wyburn KR, Jose MD, Wu H, et al. The role of macrophages in allograft rejection. Transplantation 2005; 80:1641-1647. (Pubitemid 43053983)
14. Hancock WW, Thomson NM, Atkins RC. Composition of interstitial cellular infiltrate identified by monoclonal antibodies in renal biopsies of rejecting human renal allografts. Transplantation 1983; 35:458-463. (Pubitemid 13089917)
15. Lee I, Wang L, Wells AD, et al. Blocking the monocyte chemoattractant protein-1/CCR2 chemokine pathway induces permanent survival of islet allografts through a programmed death-1 ligand-1-dependent mechanism. J Immunol 2003; 171:6929-6935. (Pubitemid 37532129)
16. Le MY, Jose MD, Mu W, et al. Macrophage colony-stimulating factor expression and macrophage accumulation in renal allograft rejection. Transplantation 2002; 73:1318-1324. (Pubitemid 34454282)
17. Jose MD, Le MY, Atkins RC, Chadban SJ. Blockade of macrophage colonystimulating factor reduces macrophage proliferation and accumulation in renal allograft rejection. Am J Transplant 2003; 3:294-300. (Pubitemid 36407047)
18. Tinckam KJ, Djurdjev O, Magil AB. Glomerular monocytes predict worse outcomes after acute renal allograft rejection independent of C4d status. Kidney Int 2005; 68:1866-1874. (Pubitemid 43169933)
19. Kirk AD, Hale DA, Mannon RB, et al. Results from a human renal allograft tolerance trial evaluating the humanized CD52-specific monoclonal antibody alemtuzumab (CAMPATH-1H). Transplantation 2003; 76:120-129. (Pubitemid 36877125)
20. Magil AB, Tinckam K. Monocytes and peritubular capillary C4d deposition in acute renal allograft rejection. Kidney Int 2003; 63:1888-1893. (Pubitemid 36513338)
21. Fahim T, Bohmig GA, Exner M, et al. The cellular lesion of humoral rejection: Predominant recruitment of monocytes to peritubular and glomerular capillaries. Am J Transplant 2007; 7:385-393. (Pubitemid 46096331)
22. Kozakowski N, Bohmig GA, Exner M, et al. Monocytes/macrophages in kidney allograft intimal arteritis: No association with markers of humoral rejection or with inferior outcome. Nephrol Dial Transplant 2009; 24:1979-1986.
23. Nankivell BJ, Chapman JR. The significance of subclinical rejection and the value of protocol biopsies. Am J Transplant 2006; 6:2006-2012. (Pubitemid 44199535)
24. Girlanda R, Kleiner DE, Duan Z, et al. Monocyte infiltration and kidney allograft dysfunction during acute rejection. Am J Transplant 2008; 8:600-607. (Pubitemid 351287541)
25. Hoffmann U, Bergler T, Segerer S, et al. Impact of chemokine receptor CX3CR1 in human renal allograft rejection. Transpl Immunol 2010; 23:204-208.
26. Sis B, Mengel M, Haas M, et al. Banff '09 meeting report: Antibody mediated graft deterioration and implementation of Banff working groups. Am J Transplant 2010; 10:464-471.
27. Trieb K, Dirnhofer S, Krumbock N, et al. Heat shock protein expression in the transplanted human kidney. Transpl Int 2001; 14:281-286. (Pubitemid 33021057)
28. Grone HJ, Weber C, Weber KS, et al. Met-RANTES reduces vascular and tubular damage during acute renal transplant rejection: Blocking monocyte arrest and recruitment. FASEB J 1999; 13:1371-1383. (Pubitemid 29382505)
29. Gao W, Topham PS, King JA, et al. Targeting of the chemokine receptor CCR1 suppresses development of acute and chronic cardiac allograft rejection. J Clin Invest 2000; 105:35-44. (Pubitemid 30036385)
30. Gao W, Faia KL, Csizmadia V, et al. Beneficial effects of targeting CCR5 in allograft recipients. Transplantation 2001; 72:1199-1205. (Pubitemid 33026595)
31. Takeiri M, Tachibana M, Kaneda A, et al. Inhibition of macrophage activation and suppression of graft rejection by DTCM-glutarimide, a novel piperidine derived from the antibiotic 9-methylstreptimidone. Inflamm Res 2011; 60:879-888.
32. Jose MD, Ikezumi Y, van Rooijen N, et al. Macrophages act as effectors of tissue damage in acute renal allograft rejection. Transplantation 2003; 76:1015-1022. (Pubitemid 37280827)
33. Qi F, Adair A, Ferenbach D, et al. Depletion of cells of monocyte lineage prevents loss of renal microvasculature in murine kidney transplantation. Transplantation 2008; 86:1267-1274.
34. Hutchinson JA, Riquelme P, Geissler EK, Fandrich F. Human regulatory macrophages. Methods Mol Biol 2011; 677:181-192.
35. Hutchinson JA, Riquelme P, Sawitzki B, et al. Immunological consequences and trafficking of human regulatory macrophages administered to renal transplant recipients. J Immunol 2011; 187:2072-2078.
36. Mannon RB, Kopp JB, Ruiz P, et al. Chronic rejection of mouse kidney allografts. Kidney Int 1999; 55:1935-1944. (Pubitemid 29197982)
37. Pilmore HL, Painter DM, Bishop GA, et al. Early up-regulation of macrophages and myofibroblasts: A new marker for development of chronic renal allograft rejection. Transplantation 2000; 69:2658-2662. (Pubitemid 30482035)
38. Yang J, Reutzel-Selke A, Steier C, et al. Targeting of macrophage activity by adenovirus-mediated intragraft overexpression of TNFRp55-Ig, IL-12p40, and vIL-10 ameliorates adenovirus-mediated chronic graft injury, whereas stimulation of macrophages by overexpression of IFN-gamma accelerates chronic graft injury in a rat renal allograft model. J Am Soc Nephrol 2003; 14:214-225. (Pubitemid 36026312)
39. Kitchens WH, Chase CM, Uehara S, et al. Macrophage depletion suppresses cardiac allograft vasculopathy in mice. Am J Transplant 2007; 7:2675-2682. (Pubitemid 350045773)
40. Alpers CE, Davis CL, Barr D, et al. Identification of platelet-derived growth factor A and B chains in human renal vascular rejection. Am J Pathol 1996; 148:439-451. (Pubitemid 26056729)
41. Ashokkumar C, Ningappa M, Ranganathan S, et al. Increased expression of peripheral blood leukocyte genes implicate CD14 tissue macrophages in cellular intestine allograft rejection. Am J Pathol 2011; 179:1929-1938.
42. Slegers TP, van Rooijen N, van Rij G, van der Gaag R. Delayed graft rejection in prevascularised corneas after subconjunctival injection of clodronate liposomes. Curr Eye Res 2000; 20:322-324. (Pubitemid 30428162)
43. Fox A, Koulmanda M, Mandel TE, et al. Evidence that macrophages are required for T-cell infiltration and rejection of fetal pig pancreas xenografts in nonobese diabetic mice. Transplantation 1998; 66:1407-1416. (Pubitemid 29014018)
44. Yi S, Hawthorne WJ, Lehnert AM, et al. T cell-activated macrophages are capable of both recognition and rejection of pancreatic islet xenografts. J Immunol 2003; 170:2750-2758. (Pubitemid 36245670)